Navigation Links
Berlin Heart Announces Restructuring of Management

BERLIN, July 7 /PRNewswire/ -- Ulrich Stroeher, Chairman of the Advisory Board of Berlin Heart, today announced that Dr. Johannes Mueller is leaving the general management of the company on 30 September 2009.

Dr. Mueller belongs to the company's founders and is one of the intellectual fathers of the successful ventricular assist device INCOR(R). He will continue to contribute his wealth of experience in this area as coordinator for projects with external cooperation partners. He will further support the company in developing new markets.

Dr. Mueller was a member of the general management from the very beginning when the company was founded as a start-up enterprise with venture capital in 1996. In October 2006 Berlin Heart AG was acquired by Syscore GmbH and the legal structure was changed to GmbH. Today Berlin Heart has 220 employees and is one of the three worldwide leading medical device companies in the area of mechanical heart support.

On 1 October 2009 Dr. Stefan Thamasett will join the general management of Berlin Heart. Dr. Thamasett has more than seven years of experience in clinical cardiology and possesses long-standing experience as head of marketing and sales in well-known medical device companies. He will manage the company together with Dr. Dirk Lauscher, the company's present General Manager.

About Berlin Heart

Berlin Heart is the only company worldwide that develops, produces, and distributes implantable and external ventricular assist devices for patients of every age and body size. The products EXCOR(R) and INCOR(R) provide mechanical support of the heart for patients suffering from severe end-stage heart failure. The ventricular assist device EXCOR(R) Pediatric is used in infants, children, and teenagers and is leading the worldwide market. EXCOR(R) Pediatric is currently under clinical investigation for pediatric patients in USA. All other products are not approved in USA. Further information on the Berlin Heart products is available under:

Contact: Linda Buerk Manager Marketing & PR Phone: +49-(0)30-8187-2650 Mobile: +49-(0)173-629-0803

SOURCE Berlin Heart GmbH
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Charterhouse Group Partners with MTS Health Investors and Highlander Partners to Acquire Chamberlin Edmonds & Associates, Inc., a Leading Provider of Eligibility Services to Hospitals
2. Berlin Heart Receives First Regulatory Approval in North America
3. Drug for cluster headaches may cause heart problems
4. Use of certain lipid measures not more effective in predicting coronary heart disease
5. Restricting Blood Flow May Help Heart Bypass Patients
6. Urban Smog Tough on Young Adults Hearts
7. Stanford study highlights cost-effective method of lowering heart disease risks
8. Vitamin Es lack of heart benefit linked to dosage
9. Drug That Lowers Resting Heart Rate Being Tested
10. Heart Attack Boosts Diabetes Risk
11. Embryonic Stem Cells Repair Human Heart
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... strategic partnership with Connance, a healthcare industry leader providing predictive analytics to ... technology combine to provide health systems, hospitals and ambulatory surgical centers with ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Pixel Film Studios ... X. , "Film editors can give their videos a whole new perspective by using ... - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Calif. , June 23, 2016 Any dentist ... many challenges of the current process. Many of them do ... of the technical difficulties and high laboratory costs involved. And ... to offer it at such a high cost that the ... it. Dr. Parsa Zadeh , founder of ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: